New York OKs SEQUENOM's prenatal test

12/28/2007 | Forbes

New York has granted SEQUENOM approval for its noninvasive prenatal test used to detect Rhesus D incompatibility, a fetal disorder that can cause anemia and mental retardation. The test uses SEQureDx technology to draw out fetal nucleic acid material from the mother's blood sample.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC